| 000 | 00937 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512022815.0 | ||
| 264 | 0 | _c19850802 | |
| 008 | 198508s 0 0 eng d | ||
| 022 | _a0586-7614 | ||
| 024 | 7 |
_a10.1093/schbul/11.2.187 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJones, B D | |
| 245 | 0 | 0 |
_aTardive dysmentia : further comments. _h[electronic resource] |
| 260 |
_bSchizophrenia bulletin _c1985 |
||
| 300 |
_a187-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurocognitive Disorders _xetiology |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xetiology |
| 773 | 0 |
_tSchizophrenia bulletin _gvol. 11 _gno. 2 _gp. 187-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/schbul/11.2.187 _zAvailable from publisher's website |
| 999 |
_c2867498 _d2867498 |
||